Overview

A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome

Status:
Completed

Trial end date:
2019-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether antibiotics given immediately after birth alter the development of the developing preterm infant's microbiome, which may further alter overall clinical outcomes.

Phase:

N/A

Details

Lead Sponsor:

University of Chicago

Treatments:

Ampicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Gentamicins